Skip to content
Lower risk Medical device recall · FDA · Published June 12, 2017

Roche Accu-Chek Aviva II Meter Recall: Damaged Capacitor Causes Power Issues

Roche recalls Accu-Chek Aviva II meters with damaged capacitors that may cause short battery life or failure to turn on. Affected units have specific serial numbers.

🇺🇸 FDA recall #Z-2765-2019Medical deviceRoche ›
Take action

Contact the company

Recalling firmRoche Diabetes Care, Inc.9115 Hague Rd · Indianapolis, IN 46256-1025
✎ GovInfoNow plain-language explainer

What happened, in plain English

Roche is recalling Accu-Chek Aviva II blood glucose meters that may have a damaged capacitor causing power issues like short battery life or the meter not turning on. This could affect people who rely on these meters for diabetes monitoring. Read more at govinfonow.com/recall/73876-roche-accu-chek-aviva-ii-meter-recall-damaged-capacitor-causes.

Source Summary by GovInfoNow · govinfonow.com/recall/73876-roche-accu-chek-aviva-ii-meter-recall-damaged-capacitor-causes · Updated September 23, 2026 · FDA enforcement record: FDA #Z-2765-2019

Cite this page

“Roche Accu-Chek Aviva II Meter Recall: Damaged Capacitor Causes Power Issues.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/73876-roche-accu-chek-aviva-ii-meter-recall-damaged-capacitor-causes. Based on FDA recall #Z-2765-2019 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2765-2019%22&limit=1).

Why it’s dangerous

Damaged capacitors in the meter can cause power problems such as short battery life or the meter failing to turn on. This might lead to inaccurate glucose readings if the meter doesn't function properly.

Who’s affected

People with diabetes who use the Accu-Chek Aviva II meter for home blood glucose testing are most at risk. The recall affects specific serial number ranges.

How to tell if you have this one

Check the serial number on your meter. Affected units have serial numbers between XXX20000000 and XXX23284925, or less than XXX06335297 (updated ranges on 10/12/2019 and 10/18/2019).

  • Brand
    Roche
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Worldwide distribution - US Nationwide distribution.
Recall numberProduct, codes & lotsQuantity
Z-2765-2019Accu-Chek Aviva II Meter - Product Usage: a. The Accu-Chek Aviva Plus Blood Glucose Monitoring System is intended to be used for the quantitative measurement of glucose (sugar) in fresh capillary whole blood samples drawn from the fingertips, forearm, upper arm, or palm. The Accu-Chek Aviva Plus Blood Glucose Monitoring System is intended to be used by a single person and should not be shared. b. The Accu-Chek Aviva Plus Blood Glucose Monitoring System is intended for self-testing outside the body (in vitro diagnostic use) by people with diabetes at home as an aid to monitor the effectiveness of diabetes control. The Accu-Chek Aviva Plus Blood Glucose Monitoring System should not be used for the diagnosis of or screening of diabetes or for neonatal use. Alternative site testing should be done only during steady state times (when glucose is not changing rapidly). c. The Accu-Chek Aviva Plus Test Strips are for use with the Accu-Chek Aviva Blood Glucose Meter to quantitatively measure glucose (sugar) in fresh capillary whole blood samples drawn from the fingertips, forearm, upper arm, or palm.; Serial numbers between xxx20000000 and xxx23284925, or less than xxx06335297 Updated serial numbers on 10/12/2019: Aviva II: Between XXX20000000 and XXX23284925 Updated 10/18/2019: Aviva II from XXX05000001 to XXX06335297 OR from XXX20000000 to XXX2328492526,600
Z-2766-2019Accu-Chek Performa II Meter - Product Usage: a. The Accu-Chek Aviva Plus Blood Glucose Monitoring System is intended to be used for the quantitative measurement of glucose (sugar) in fresh capillary whole blood samples drawn from the fingertips, forearm, upper arm, or palm. The Accu-Chek Aviva Plus Blood Glucose Monitoring System is intended to be used by a single person and should not be shared. b. The Accu-Chek Aviva Plus Blood Glucose Monitoring System is intended for self-testing outside the body (in vitro diagnostic use) by people with diabetes at home as an aid to monitor the effectiveness of diabetes control. The Accu-Chek Aviva Plus Blood Glucose Monitoring System should not be used for the diagnosis of or screening of diabetes or for neonatal use. Alternative site testing should be done only during steady state times (when glucose is not changing rapidly). c. The Accu-Chek Aviva Plus Test Strips are for use with the Accu-Chek Aviva Blood Glucose Meter to quantitatively measure glucose (sugar) in fresh capillary whole blood samples drawn from the fingertips, forearm, upper arm, or palm.; Serial numbers less than xxx25525056 Updated serial numbers on 10/12/2019: Performa II: Between XXX20000000 and XXX25525056 Updated 10/18/2019: Performa II: from XXX20000000 to XXX25525056N/A
Based on the official FDA remedy

What to do — step by step

  1. Check Serial Number

    Look for the serial number on your meter to see if it falls within the affected ranges: XXX20000000 to XXX23284925 or less than XXX06335297.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide distribution - US Nationwide distribution.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 3.4 years after the firm started it.

1. Firm started the recall: Jun 12, 201712. FDA classified it Class II: Sep 30, 201923. Published in FDA’s Enforcement Report: Oct 9, 201934. FDA terminated the recall: Oct 30, 2020420172020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2765-2019 (June 12, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2765-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA